Your browser doesn't support javascript.
loading
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao, Yungan; Sun, Xu-Shan; Pointreau, Yoann; Le Tourneau, Christophe; Sire, Christian; Kaminsky, Marie-Christine; Coutte, Alexandre; Alfonsi, Marc; Calderon, Benôit; Boisselier, Pierre; Martin, Laurent; Miroir, Jessica; Ramee, Jean-Francois; Delord, Jean-Pierre; Clatot, Florian; Rolland, Frederic; Villa, Julie; Magne, Nicolas; Elicin, Olgun; Gherga, Elisabeta; Nguyen, France; Lafond, Cédrik; Bera, Guillaume; Calugaru, Valentin; Geoffrois, Lionnel; Chauffert, Bruno; Damstrup, Lars; Crompton, Philippa; Ennaji, Abdallah; Gollmer, Kathrin; Nauwelaerts, Heidi; Bourhis, Jean.
Afiliação
  • Tao Y; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
  • Sun XS; Department of Radiation Oncology, Nord Franche-Comté de Montbéliard and CHRU de Besançon, Besançon, France.
  • Pointreau Y; Oncologie-Radiothérapie, Institut Inter-Régional de Cancérologie, Centre Jean Bernard, Le Mans, France.
  • Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris, France.
  • Sire C; South Brittany Hospital Center, Hôpital du Scorff Radiothérapie, Lorient, France.
  • Kaminsky MC; Institut Cancérologie de Lorraine - Alexis Vautrin, Oncologie Médicale, Vandoeuvre-lès-Nancy, France.
  • Coutte A; CHU Amiens Picardie, Oncologie-Radiothérapie, Amiens, France.
  • Alfonsi M; Institut Sainte Catherine, Radiothérapie, Avignon, France.
  • Calderon B; Institut Sainte Catherine, Radiothérapie, Avignon, France.
  • Boisselier P; Institut du Cancer de Montpellier, Val d'Aurelle, Oncologie-Radiothérapie, Montpellier, France.
  • Martin L; Centre de Radiothérapie Guillaume le Conquérant, Le Havre, France.
  • Miroir J; Jean Perrin Center, Radiothérapie, Clermont-Ferrand, France.
  • Ramee JF; CHD Vendée, Radiothérapie, La Roche-sur-Yon, France.
  • Delord JP; Medical Oncology Dept, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Clatot F; Henri Becquerel Centre, Service Oncologie Médicale rue d'Amiens, Rouen, France.
  • Rolland F; Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France.
  • Villa J; CHU Grenoble, Radiothérapie, Pôle de Cancérologie, Grenoble, France.
  • Magne N; Institut de Cancérologie Lucien Neuwirth, Radiothérapie, Saint-Priest-en-Jarez, France.
  • Elicin O; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gherga E; Department of Radiation Oncology, Nord Franche-Comté de Montbéliard and CHRU de Besançon, Besançon, France.
  • Nguyen F; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
  • Lafond C; Oncologie-Radiothérapie, Institut Inter-Régional de Cancérologie, Centre Jean Bernard, Le Mans, France.
  • Bera G; South Brittany Hospital Center, Hôpital du Scorff Radiothérapie, Lorient, France.
  • Calugaru V; Radiotherapy Oncology Department, Institut Curie, Paris-Saclay University, Paris, France.
  • Geoffrois L; Institut Cancérologie de Lorraine - Alexis Vautrin, Oncologie Médicale, Vandoeuvre-lès-Nancy, France.
  • Chauffert B; CHU Amiens Picardie, Oncologie-Radiothérapie, Amiens, France.
  • Damstrup L; Debiopharm International, Lausanne, Switzerland.
  • Crompton P; Debiopharm International, Lausanne, Switzerland.
  • Ennaji A; Debiopharm International, Lausanne, Switzerland.
  • Gollmer K; Debiopharm International, Lausanne, Switzerland.
  • Nauwelaerts H; Debiopharm International, Lausanne, Switzerland.
  • Bourhis J; CHUV, Radiation Oncology Department, Bâtiment Hospitalier, Lausanne, Switzerland. Electronic address: jean.bourhis@chuv.ch.
Eur J Cancer ; 183: 24-37, 2023 04.
Article em En | MEDLINE | ID: mdl-36796234
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França